DRUG · Unmapped registry intervention
0.5% timolol
Find medicine records ·
Find other trials using this name
Clinical trial
24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension
NCT01655758
Drugs and interventions used in this trial
5 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
timolol-dorzolamide fixed combination
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Latanoprost
Normalized identity: latanoprostView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Travoprost
Normalized identity: travoprostView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Bimatoprost
Normalized identity: bimatoprostView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backed24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
0.5% timololDRUG
LatanoprostDRUG · verified · RxNorm: latanoprost
TravoprostDRUG · verified · RxNorm: travoprost
BimatoprostDRUG · verified · RxNorm: bimatoprost
Sponsors & collaborators
University of Parmalead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01655758 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.